Quick Answer
Praxis Precision Medicines, Inc. reported Shares Outstanding of 25.20 million shares for fiscal year 2025.
Praxis Precision Medicines, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 25.20M | +29.7% |
| 2024 | 19.42M | +120.9% |
| 2023 | 8.79M | +167.1% |
| 2022 | 3.29M | -92.7% |
| 2021 | 45.30M | +18.4% |
| 2020 | 38.27M | +2259.5% |
| 2019 | 1.62M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 21.17M | +19.0% | +0.6% |
| June 30, 2025 | 21.04M | +18.5% | +3.4% |
| March 31, 2025 | 20.34M | +53.4% | +4.7% |
| December 31, 2024 | 19.42M | +120.9% | +9.2% |
| September 30, 2024 | 17.79M | -86.2% | +0.2% |
| June 30, 2024 | 17.76M | -86.2% | +33.9% |
| March 31, 2024 | 13.26M | -77.1% | +50.8% |
| December 31, 2023 | 8.79M | -82.2% | -93.2% |
- Praxis Precision Medicines, Inc. showed an increase of +29.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Praxis Precision Medicines, Inc.’s shares outstanding has grown by 1453.4% (from 1.62 million shares to 25.20 million shares).
- The most recent figure is from Praxis Precision Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: